Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Møreforsking AS | OTHER |
Not provided
Not provided
Not provided
Not provided
The skin acts as a barrier against the external environment and prevents water loss from the body. Aging is a natural process leading to changes in the skin and fish oil has been shown to prevent inflammation, hyperpigmentation and UV-damage. This pilot study will determine skin characteristics after intervention with north atlantic fish oil.
Women will be recruited to a placebo or fish oil group and be examined at pre- and post for skin quality parameters such as wrinkles, fine lines and trans-epithelial water loss.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Placebo | Placebo Comparator | 4x1g corn oil capsules |
|
| Ceto 10 | Experimental | 4x1g capsules containing containing broad spectrum marine oil from north atlantic fish |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Placebo | Dietary Supplement | 1g corn oil capsules |
| |
| Ceto 10 |
| Measure | Description | Time Frame |
|---|---|---|
| Determine the change in skin quality of healthy women after supplementation with fish oil compared to corn oil | Changes in quantitative analysis of facial inflammation, wrinkles and fine lines and skin texture will be performed using the VISIA Skin Analysis system. Measurements will be made at baseline and at end of supplementation period. | 3 months |
| Measure | Description | Time Frame |
|---|---|---|
| Determine the change in omega-3 index (%EPA and DHA in red blood cells) after daily intake of 4g of north atlantic fish oil compared to placebo | Fatty acid profiles will be measured from blood samples using the Omega-quant test | 3 months |
Not provided
Inclusion Criteria:
Healthy women in the age of 30-65
Able to follow the following dietary restriction for 4 months (4 weeks wash-out, 3 months intervention):
Exclusion Criteria:
Pregnancy or breast feeding known allergy to seafood skin treatment the last 6 months planned skin treatment during the study period
-
Participation is based on self-assessment of gender identity
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Derek Tobin, PhD | Contact | derek.tobin@pelagia.com |
| Name | Affiliation | Role |
|---|---|---|
| Lisa Midtbø, PhD | Møreforsking AS | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Møreforsking AS | Recruiting | Ålesund | 6006 | Norway |
Data will be presented as collective statistical data. Individual participant data may be shared on request, or if demanded by journals
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D007249 | Inflammation |
| ID | Term |
|---|---|
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
Placebo controlled, double blind intervention study.
Not provided
Not provided
Interventions are given as 1g bovine capsules of equal size, weight and appearance, and provided in identical bottles with a coded label.
| Dietary Supplement |
1g capsules containing oil broad spectrum marine oil from north atlantic fish |
|